Tiotropizone (Tiotropex)
Product detail for Tiotropizone, INN: tiotropizone. Therapeutic area: Respiratory. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-013
INN
tiotropizone
Therapeutic Area
Respiratory
Status
Pending
Owner
James O'Brien
Created
2022-12-19
Last Updated
2023-08-31
Markets
8
Presentations
| Form | Strength | Route |
|---|---|---|
| Hard capsule | 1 mg/mL | Intravitreal |
| Oral solution | 0.5 mg | Topical |
| Solution for injection | 100 mg | Transdermal |
| Soft capsule | 50 mg | Topical |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-028 | Crizotinabex | crizotinabex | 53331-43-5 | small-molecule | Pending |
| SUB-035 | Sucrose | sucrose | 65466-67-2 | combination | Pending |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| CDSCO-2022-0013 | Spain | NDA | In Progress | Marcus Webb | 2023-07-05 |
| PMDA-2022-0043 | Spain | Label Update | Pending | Aisha Okonkwo | 2024-05-22 |
| CDSCO-2022-0073 | Spain | MAA | Overdue | Marcus Webb | 2023-05-01 |
Markets (8)